Impact Biomedical (IBO) EBIT Margin (2022 - 2026)
Impact Biomedical's EBIT Margin was -3085.71% in Q3 2026, up 2180.95 percentage points from -5266.67% a year earlier and up 20314.29 percentage points from the prior quarter.
Powered by 
Analysis
Impact Biomedical (IBO) EBIT Margin (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Impact Biomedical's EBIT Margin was -12655.26% through Sep 30, 2026, up 81996.35 percentage points year-over-year; for FY2025, it came in at -13381.25%, up 207795.67 percentage points from FY2024.
- EBIT Margin shows a three-year change of -6573.25 percentage points (FY2022 to FY2025).
- In earlier years, EBIT Margin was -221176.92% in FY2024 (-190192.31 pp), -30984.62% in FY2023 (-24176.62 pp) and -6808.00% in FY2022.
- The Q3 2026 figure marks the highest quarterly EBIT Margin since Q2 2022.
- Compared with a year earlier, EBIT Margin was higher in five of the last eight quarters, with an average year-over-year change of +5775.00 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q4 2025 (a gain of 857652.38 percentage points); the worst was Q4 2024 (a drop of 836400.00 percentage points).
- Per Business Quant data, IBO's EBIT Margin in the three quarters before Q3 2026 was -23400.00% (Q2 2026), -32700.00% (Q1 2026) and -16714.29% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 32.98% |
| 10 | Impact Biomedical | 43.92 Mn | 47.11 Mn | 15,000.00 | -3,085.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -3,085.71% |
| Jun 30, 2026 | -23,400.00% |
| Mar 31, 2026 | -32,700.00% |
| Dec 31, 2025 | -16,714.29% |
| Sep 30, 2025 | -5,266.67% |
| Jun 30, 2025 | -16,471.43% |
| Mar 31, 2025 | -33,666.67% |
| Dec 31, 2024 | -874,366.67% |
| Sep 30, 2024 | -37,566.67% |
| Jun 30, 2024 | -20,866.67% |
| Mar 31, 2024 | -25,700.00% |
| Dec 31, 2023 | -37,966.67% |
| Sep 30, 2023 | -35,933.33% |
| Jun 30, 2022 | -1,500.00% |
API Access
Impact Biomedical EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();